Profile
Cynthia Seidel-Dugan worked as the Chief Scientific Officer at Potenza Therapeutics, Inc. from 2018 to 2018.
Prior to that, she was the Vice President-Biology at CoStim Pharmaceuticals, Inc. from 2013 to 2014.
Currently, she is the Chief Scientific Officer at Werewolf Therapeutics, Inc. from 2019 to 2024.
Dr. Seidel-Dugan holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from The College of William & Mary.
Former positions of Cynthia Seidel-Dugan
| Companies | Position | End |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 29/03/2024 |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Develops oncology programs and mechanisms for tumors detection | Corporate Officer/Principal | 01/12/2018 |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Corporate Officer/Principal | 01/02/2014 |
Training of Cynthia Seidel-Dugan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Develops oncology programs and mechanisms for tumors detection | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The College of William & Mary
The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Health Technology |
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
- Stock Market
- Insiders
- Cynthia Seidel-Dugan
















